We serve Chemical Name:1-(4-methoxynaphthalen-1-yl)ethanone CAS:24764-66-7 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:1-(4-methoxynaphthalen-1-yl)ethanone
CAS.NO:24764-66-7
Synonyms:4′-methoxy-1′-acetonaphthone;1-acetyl-4-methoxynaphthalene;1-(4-Methoxynaphthalen-1-yl)ethanone
Molecular Formula:C13H12O2
Molecular Weight:200.23300
HS Code:2914509090
Physical and Chemical Properties:
Melting point:N/A
Boiling point:366.2ºC at 760mmHg
Density:1.118g/cm3
Index of Refraction:1.594
PSA:26.30000
Exact Mass:200.08400
LogP:3.05100
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like 4′-methoxy-1′-acetonaphthone chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,1-(4-Methoxynaphthalen-1-yl)ethanone physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,4′-methoxy-1′-acetonaphthone Use and application,4′-methoxy-1′-acetonaphthone technical grade,usp/ep/jp grade.
Related News: AbbVie and Johnson & Johnson already boast three FDA-approved regimens for Imbruvica in newly diagnosed chronic lymphocytic leukemia (CLL). Now, the pair aims to add another to the drug’s label, one that could shorten the time patients need to stay on treatment. 1-(4-methoxynaphthalen-1-yl)ethanone manufacturer ICIG has agreed to offer employment to the unit��s approximately 120 employees upon closing, and plans to maintain operations at its primary location, a manufacturing facility in Liestal, Switzerland. 1-(4-methoxynaphthalen-1-yl)ethanone supplier AbbVie and Johnson & Johnson already boast three FDA-approved regimens for Imbruvica in newly diagnosed chronic lymphocytic leukemia (CLL). Now, the pair aims to add another to the drug’s label, one that could shorten the time patients need to stay on treatment. 1-(4-methoxynaphthalen-1-yl)ethanone vendor AbbVie and Johnson & Johnson already boast three FDA-approved regimens for Imbruvica in newly diagnosed chronic lymphocytic leukemia (CLL). Now, the pair aims to add another to the drug’s label, one that could shorten the time patients need to stay on treatment. 1-(4-methoxynaphthalen-1-yl)ethanone factory The downstream industry of the pharmaceutical intermediate industry is mainly the production of APIs, and the relationship between APIs and preparations is in the upstream and downstream industry chain. The consumer demand for downstream preparations will directly affect the demand for APIs.
